Literature DB >> 7439544

Increased integrated concentration of norepinephrine, epinephrine, aldosterone, and growth hormone in patients with uncontrolled juvenile diabetes mellitus.

Z Zadik, R Kayne, M Kappy, L P Plotnick, A A Kowarski.   

Abstract

The 24-h integrated plasma concentration of glucose (IC-glucose), norepinephrine (IC-NE), epinephrine (IC-E), cortisol (IC-F), growth hormone (IC-GH), aldosterone (IC-ALDO), and plasma renin activity (IC-PRA) were measured in 11 nonobese juvenile-onset nonketotic diabetic patients exhibiting hyperglycemia and glycosuria and 34 matched control subjects using a portable pump, drawing blood at a constant rate through a nonthrombogenic i.v. catheter. The diabetic patients had a noticeable rise of their IC-NE, IC-E, IC-GH, and IC-ALDO. There was no significant difference between the IC-F and IC-PRA of the patients and the control subjects.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7439544     DOI: 10.2337/diab.29.8.655

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  5 in total

1.  POTENTIAL NON-GROWTH USES OF rhIGF-I.

Authors:  Roy J Kim; Adda Grimberg
Journal:  Growth Genet Horm       Date:  2007-03

2.  Hyperaldosteronism in ketoacidosis and in poorly controlled non-ketotic diabetes.

Authors:  C Quigley; P A Sullivan; H Gonggrijp; M J Crowley; J B Ferriss; D J O'Sullivan
Journal:  Ir J Med Sci       Date:  1982-05       Impact factor: 1.568

Review 3.  Diabetes and arterial hypertension.

Authors:  P L Drury
Journal:  Diabetologia       Date:  1983-01       Impact factor: 10.122

4.  Diabetic control in children and adolescents: Psychosocial factors and therapeutic efficacy.

Authors:  P Barglow; D V Edidin; A S Budlong-Springer; D Berndt; R Phillips; E Dubow
Journal:  J Youth Adolesc       Date:  1983-04

5.  Diastolic function is reduced in adolescents with type 1 diabetes in response to exercise.

Authors:  Silmara Gusso; Teresa E Pinto; James C Baldi; Elizabeth Robinson; Wayne S Cutfield; Paul L Hofman
Journal:  Diabetes Care       Date:  2012-07-06       Impact factor: 19.112

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.